It has also aggressively invested in gene editing, including its 2025 acquisition of cardiovascular disease gene-editing ...

Are there significant gains ahead for one (or both) of these innovative biotechs?

One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk profiles stack up for 2026.

The benefits of investing in gene-editing stocks include: Significant long-term growth potential. Gene editing is now a proven technology. Potential for acquisition by larger drugmakers. Most ...

There could be additional catalysts for this drugmaker over the next year.

In this article, we will take a look at the 9 Best Gene-Editing Stocks to Buy According to Hedge Funds. Genetic manipulation – or gene editing – is a concept that describes altering the genetic ...

(NTLA) jumped about 5% in premarket trading on Monday after the company unveiled additional Phase 3 data showing that a ...

The gene-editing niche of the biotech industry is gaining momentum, as various companies focused on these techniques -- which allow scientists to alter patients' DNA to treat some diseases -- have ...

Gene therapy and gene editing are marvels of modern biotechnology, providing revolutionary techniques for fixing genetic abnormalities. Gene therapy introduces functional genetic material to treat ...